Tag: USP 797

Compounding Allergenic Extracts Safely with USP 797 Guidelines

  Allergy and ENT practices must follow USP 797 when mixing patient-specific allergen extracts for subcutaneous immunotherapy (ACAAI 2023). Section 21 of USP 797 details the requirements for allergen extract compounding to reduce the chance of contamination and protect the patient’s overall health. Requirements apply for mixing allergen extracts for allergy testing and regular immunotherapy…. Learn More

Portable Clean Rooms – Generation II – New Line from Sentry Air

Introducing Portable Clean Rooms – Generation II (PCR2). This system features an updated design that provides the operator with easy fan control, improved airflow, and efficiency. This line also offers larger sizes with the same dependability. Portable Clean Rooms – Generation II Updated Features Clean and Sleek Look The Portable Clean Room Generation II offers… Learn More

USP 797 Guidelines for IV Bag Preparation

The official date for USP 797 is steadily approaching. The latest revision of guidelines defines proper sterile compounding procedures for CSP’s (compounded sterile preparations) including injections, infusions, and IV bags. By November 1, 2023 applicable facilities must follow all guidelines in order to preserve medication quality. USP 797 sterile compounding rules applies to hospitals, other… Learn More